The global antacids market size is expected to around USD 8.4 billion by 2026, this market is foreseen to develop with 4.4% CAGR during the forecast time period.
Changing dietary propensities is one of the main considerations expected to fuel the development forthcoming years. Also irregular eating and sleeping patterns are the other region which may drive acidy in the population, which is projected to drive the growth of the market.
Expanding commonness of Gastro Esophageal Reflux Diseases (GERD) is relied upon to influence the general market over the forthcoming years. As per the Gut journal, distributed by the International Foundation for Gastrointestinal Disorders; in 2017, the pervasiveness of GERD was around 18% to 28% in North America, 9% to 26% in Europe, 3% to 8% in East Asia, 9% to 33% in Middle East, 12% in Australia, and 23% in South America.
Tablet was evaluated to be the biggest segment in 2018. Nearness of chewable tablets in various flavors enhances quiet adherence to the drug, which thusly is required to add to development of the portion. Tablets can give the correct measure of dose to the patients contrasted with other dose structures and they are anything but difficult to store. These components can be credited to the segment development over the forthcoming years. Other key drivers expected to encourage the segment development incorporate dispatch of new product by real players.
Fluid segment is relied upon to be the quickest developing portion in the general market forthcoming years. Nearness of key players, for example, Pfizer Inc.; GlaxoSmithKline plc. Furthermore, Dabur offering fluid acid neutralizer, is evaluated to help the segment development. Furthermore, fluid dose shape is one of favoured decisions for youngsters and older populace because of its acceptable taste. This factor is additionally foreseen to look good for market development.
Asia Pacific is required to be the biggest and quickest developing provincial segment amid the forthcoming years inferable from high neglected clinical necessities, accessibility of compelling treatment techniques, rising disposable income, and purchaser mindfulness about the accessibility of these product. Likewise, the nearness of key players, for example, Pfizer Inc.; GlaxoSmithKline plc.; Abbott is foreseen to develop the market over the forthcoming years. Enhancing healthcare system, and developing speculations by market players is relied upon to build its development.
Market By Dosage Form
Market By Distribution Channel
Market By Geography
North America is assessed to be the second biggest developing portion. This was credited to expanding stomach related confusion pervasiveness combined with purchaser attention to acid neutralizer product. In 2017, as indicated by the CDC, the quantity of visits in crisis offices with stomach related framework infections as the essential analysis was around 32.3 million. Moreover, the nearness of developed economies inside the region is adding fuel to its development in this region.
Few of the main businesses present in the global Antacids market are Procter & Gamble; laxoSmithKline plc; Pfizer Inc.; Bayer AG; Takeda Pharmaceutical Company Limited; BoehringerIngelheim International GmbH; Sun Pharmaceuticals Ltd.; Dr. Reddy’s Laboratories Ltd.; Reckitt Benckiser Group plc; and Sanofi.
The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie
The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also
The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short
The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by
The Global eclinical Solutions Market is expected to grow at a CAGR of around 9.7% from 2019 to 2026 and expected to reach the market value of around US$ 9,756 Mn by 2026. The eclinical solutions refer to the development and offering of clinical technologies and expertise which are aimed at supporting the development of the clinical process. The eclinical solutions usually involve
The Global Insulin Delivery Devices Market value is expected to reach around US$ 22.5 Bn by 2026 and growing at a CAGR of around 7.2% over the forecast period 2019 to 2026. Insulin delivery devices are used to deliver insulin to patients with Type 1 and Type 2 diabetes. Insulin is an important part of treatment for the diabetes patient which helps them to get glucose from the blood